Department of Health Services Research and Department of Public Health, Graduate School of Medicine, and Department of Clinical Epidemiology and Health Economics, School of Public Health, The University of Tokyo, Tokyo, Japan (A.M.).
Department of Health Care Policy, Harvard Medical School, Boston, Department of Medicine, Massachusetts General Hospital, Boston, and National Bureau of Economic Research, Cambridge, Massachusetts (A.B.J.).
Ann Intern Med. 2024 May;177(5):598-608. doi: 10.7326/M23-3163. Epub 2024 Apr 23.
Little is known as to whether the effects of physician sex on patients' clinical outcomes vary by patient sex.
To examine whether the association between physician sex and hospital outcomes varied between female and male patients hospitalized with medical conditions.
Retrospective observational study.
Medicare claims data.
20% random sample of Medicare fee-for-service beneficiaries hospitalized with medical conditions during 2016 to 2019 and treated by hospitalists.
The primary outcomes were patients' 30-day mortality and readmission rates, adjusted for patient and physician characteristics and hospital-level averages of exposures (effectively comparing physicians within the same hospital).
Of 458 108 female and 318 819 male patients, 142 465 (31.1%) and 97 500 (30.6%) were treated by female physicians, respectively. Both female and male patients had a lower patient mortality when treated by female physicians; however, the benefit of receiving care from female physicians was larger for female patients than for male patients (difference-in-differences, -0.16 percentage points [pp] [95% CI, -0.42 to 0.10 pp]). For female patients, the difference between female and male physicians was large and clinically meaningful (adjusted mortality rates, 8.15% vs. 8.38%; average marginal effect [AME], -0.24 pp [CI, -0.41 to -0.07 pp]). For male patients, an important difference between female and male physicians could be ruled out (10.15% vs. 10.23%; AME, -0.08 pp [CI, -0.29 to 0.14 pp]). The pattern was similar for patients' readmission rates.
The findings may not be generalizable to younger populations.
The findings indicate that patients have lower mortality and readmission rates when treated by female physicians, and the benefit of receiving treatments from female physicians is larger for female patients than for male patients.
Gregory Annenberg Weingarten, GRoW @ Annenberg.
目前尚不清楚医生的性别对患者临床结局的影响是否因患者的性别而异。
研究在患有内科疾病住院的女性和男性患者中,医生的性别与医院结局之间的关联是否存在差异。
回顾性观察性研究。
医疗保险索赔数据。
2016 年至 2019 年期间患有内科疾病并接受住院医师治疗的医疗保险按服务付费受益人的随机样本的 20%。
主要结局为患者 30 天死亡率和再入院率,根据患者和医生的特征以及医院暴露水平的平均值进行调整(有效地比较同一医院内的医生)。
在 458108 名女性和 318819 名男性患者中,分别有 142465(31.1%)和 97500(30.6%)名患者接受了女性医生的治疗。女性和男性患者在接受女性医生治疗时的患者死亡率均较低;然而,女性患者从女性医生处获得治疗的益处大于男性患者(差异差异,-0.16 个百分点[95%CI,-0.42 至 0.10 个百分点])。对于女性患者,女性医生和男性医生之间的差异很大且具有临床意义(调整后的死亡率,8.15%比 8.38%;平均边缘效应[AME],-0.24 个百分点[CI,-0.41 至-0.07 个百分点])。对于男性患者,可以排除女性医生和男性医生之间的重要差异(10.15%比 10.23%;AME,-0.08 个百分点[CI,-0.29 至 0.14 个百分点])。对于患者的再入院率,也存在类似的模式。
研究结果可能不适用于更年轻的人群。
研究结果表明,女性患者接受女性医生治疗时死亡率和再入院率较低,而女性患者从女性医生处获得治疗的益处大于男性患者。
格雷戈里·安纳伯格·温加滕,GRoW@安纳伯格。